Sell Dr. Reddy's Laboratories, target Rs 1,970: Chandan Taparia
Sell Dr. Reddy's Laboratories Ltd. at a price target of Rs 1970.0 and a stop loss at Rs 2122 from entry point.
By ETMarkets.com |
Chandan Taparia of Motilal Oswal Securities has a sell call on Dr. Reddy's Laboratories with a target price of Rs 1,970.
The current market price of Dr. Reddy's Laboratories is Rs 2,073.80.
Time period given by the analyst is 'Intra Day' when Dr. Reddy's Laboratories price can reach defined target.
Chandan Taparia recommended to keep a stop loss at Rs 2,122.
Dr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 34,403 Crore) operating in Pharmaceuticals and health care sector.
Company has S R Batliboi & Associates LLP as its auditors.
As on 31-12-2017, the company has a total of 165,893,524 shares outstanding.
The current market price of Dr. Reddy's Laboratories is Rs 2,073.80.
Time period given by the analyst is 'Intra Day' when Dr. Reddy's Laboratories price can reach defined target.
Chandan Taparia recommended to keep a stop loss at Rs 2,122.
Dr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 34,403 Crore) operating in Pharmaceuticals and health care sector.
ADVERTISEMENT
The company’s top management includes Dr.Ashok S Ganguly, Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.Hans Peter Hasler, Mr.K Satish Reddy, Mr.Sridar Iyengar, Ms.Kalpana Morparia. Company has S R Batliboi & Associates LLP as its auditors.
As on 31-12-2017, the company has a total of 165,893,524 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
